News Column

AASTROM BIOSCIENCES INC FILES (8-K/A) Disclosing Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

June 16, 2014



Item 2.01. Completion of Acquisition or Disposition of Assets.

This Form 8-K/A amends the Current Report on Form 8-K filed by Aastrom Biosciences, Inc. (the Company) on June 2, 2014 to provide additional financial information in connection with the acquisition by the Company of the cell therapy and regenerative medicine business (the CTRM Business) of Sanofi, a French sociÉtÉ anonyme, which was completed on May 30, 2014 (the Transaction).

Item 9.01. Financial Statements and Exhibits.

(a) Financial Statements of Business Acquired.

The Special Purpose Combined Statements of Net Assets Acquired for the CTRM Business as of March 31, 2014 (unaudited), December 31, 2013 and December 31, 2012, and the Special Purpose Combined Statements of Revenues and Direct Expenses for the three month periods ended March 31, 2014 (unaudited) and 2013 (unaudited) and for the years ended December 31, 2013 and 2012 are attached to this Form 8-K/A as Exhibit 99.1 and incorporated herein by reference.

(b) Pro Forma Financial Information.

The Pro Forma Condensed Combined Balance Sheet (unaudited) as of March 31, 2014 is attached to this Form 8-K/A as Exhibit 99.2 and incorporated herein by reference.

The Pro Forma Condensed Combined Statements of Operations (unaudited) for the year ended December 31, 2013 and for the quarter ended March 31, 2014 are attached to this Form 8-K/A as Exhibit 99.2 and incorporated herein by reference.

(d) Exhibits Exhibit No. Description 23.1 Consent of PricewaterhouseCoopers LLP, Independent Auditors. 99.1 Special Purpose Combined Statements of Net Assets Acquired for the CTRM Business as of March 31, 2014 (unaudited), December 31, 2013 and December 31, 2012, and Special Purpose Combined Statements of Revenues and Direct Expenses for the three month periods ended March 31, 2014 (unaudited) and 2013(unaudited) and for the years ended December 31, 2013 and 2012. 99.2 Pro Forma Condensed Combined Balance Sheet (unaudited) as of March 31, 2014 Pro Forma Condensed Combined Statements of Operations (unaudited) for the year ended December 31, 2013 and for the quarter ended March 31, 2014. 2



--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters